Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
SFOSF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $0 | $765 | $0 | $786 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $0 | $0 | $0 | $0 |
| Other Non-Cash | $1,078 | $291 | $0 | $1,077 |
| Operating Cash Flow | $1,078 | $1,056 | $0 | $1,863 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$955 | -$1,119 | -$1,383 | -$934 |
| Net Acquisitions | $172 | $1 | -$223 | $46 |
| Inv. Purchases | -$470 | -$75 | $86 | -$294 |
| Inv. Sales/Matur. | $592 | $1,168 | $145 | $1,079 |
| Other Inv. Act. | -$13 | -$161 | $202 | $313 |
| Investing Cash Flow | -$675 | -$185 | -$1,174 | $210 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $94 | -$79 | $472 | -$207 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$296 | -$302 | -$360 | -$1,035 |
| Other Fin. Act. | -$625 | -$253 | -$612 | -$419 |
| Financing Cash Flow | -$827 | -$634 | -$500 | -$1,662 |
| Forex Effect | $1 | $9 | $98 | -$87 |
| Net Chg. in Cash | -$422 | $246 | -$86 | -$390 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $9,637 | $9,391 | $9,477 | $9,867 |
| End Cash | $9,215 | $9,637 | $9,391 | $9,477 |
| Free Cash Flow | $123 | -$63 | $107 | $146 |